Acl Reconstruction denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for acl reconstruction are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied ACL Reconstruction as "Not FDA-Approved"

ACL reconstruction is a surgical procedure, not a drug — and surgical procedures are not subject to FDA approval in the same way pharmaceuticals are. However, Aetna may use a "not FDA-approved" or "investigational" designation to deny a specific implant, graft fixation device, or adjunctive biological product (such as a growth-factor augmentation or scaffold material) used during the reconstruction. Understanding exactly which component triggered the denial is the first step.

## Why This Denial Is Appealable

If the core reconstruction surgery itself was denied as investigational, this is almost certainly incorrect — ACL reconstruction is a well-established, widely accepted orthopedic procedure supported by major specialty societies including the American Academy of Orthopaedic Surgeons (AAOS). If a specific device or adjunct was flagged, you or your surgeon should confirm whether it carries FDA 510(k) clearance or PMA approval, and document that status explicitly in the appeal.

## Federal Appeal Framework

• Internal appeal: You have the right to a full internal appeal under ERISA §503 (employer plans) or ACA §2719 (ACA-compliant plans). Submit within the timeframe stated in your denial letter — typically 180 days.
• External review: If the internal appeal is denied, you may request an independent external review through an accredited Independent Review Organization (IRO). The external-review window is generally up to four months from final internal denial. An expedited (72-hour) external review is available when a standard timeline would seriously jeopardize your health.
• State remedies: California and many other states have additional consumer protections that may apply alongside federal rights.

## Documentation to Gather

1. Diagnosis confirmation — MRI report and orthopedic examination notes confirming complete or near-complete ACL tear with functional instability. 2. Device/implant clearance — FDA 510(k) clearance letter or PMA approval for any device your surgeon intends to use. Your surgeon's office or the device manufacturer can provide this. 3. Surgeon's medical-necessity letter — A detailed letter explaining why the chosen technique, graft type, or adjunct is the standard of care for your specific anatomy and activity demands, citing applicable AAOS or specialty-society guidance. 4. Conservative-treatment history — Documentation of any physical therapy, bracing, or activity modification attempted, with dates and outcomes. 5. Aetna's clinical policy — Request Aetna's current clinical policy bulletin for ACL reconstruction. Map each coverage criterion to your chart documentation.

## Criteria-Mapping Structure

Create a table with three columns: Aetna's stated requirement, Your supporting document, Exact chart fact. Walk through every criterion in Aetna's clinical policy and answer each one with a specific note, report, or letter. A point-by-point rebuttal is far more effective than a narrative letter alone.